OliX subsidiary mCureX partners with Samyang and GC Pharma to advance mRNA vaccines June 16, 2022 No Comments
Novel polyphenol derivative as potent DYRK1A inhibitor for the treatment of MS June 9, 2022 No Comments
Blue Water Vaccines collaborates with Instituto Butantan on universal influenza vaccine candidate May 20, 2022 No Comments
Burnet Institute and Moderna partner on novel mRNA vaccines for infectious diseases May 18, 2022 No Comments
Osivax collaborates with NIAID to combine OVX-836 with NIAID influenza vaccine candidates May 17, 2022 No Comments
Allorion Therapeutics presents TYK2 inhibitor ARTS-011 for the treatment of inflammatory disease May 13, 2022 No Comments
Celsion advances PLACCINE DNA-based vaccine platform to proof-of-concept NHP studies May 11, 2022 No Comments
RSS